INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
24/10/2022
Voltar para busca
Dado oficial do USPTO
SEIKAGAKU
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
68
Atualização mais recente
24/10/2022
Tipo de marca
Mista
Classes Nice
1, 5, 10
Data de depósito
13/03/2009
Data de registro
28/06/2011
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/12/2021
Última transação
22/12/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
Tokyo, JP
Examinador
DELGIZZI, RONALD
Unidade examinadora
L70
Descrição da marca
The mark consists of the literal element "SEIKAGAKU" and a design consisting of two oblong intersections shapes canted to the right and in the form of capsules.
Titulares e representantes
Titulares
S. C. (pessoa física)
S. C. (pessoa física)
Representantes
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
(( Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparationscosmetic preparationsfoodnutritional supplements and biomaterialstissue-engineered productsartificial skin productsartificial vitreous body products and anti-adhesive productsfor research purposes in the biomedical field; )) Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of (( pharmaceutical preparationscosmetic preparationsfoodnutritional supplements and biomaterialstissue-engineered products)) artificial skin products and corneal preservation mediumfor research purposes in the biomedical field; Chemical reagents for scientificresearch and quality control purposeslimulus amebocyte lysate reagents for use in analysis of endotoxins (( and beta-glucan; Reagentsglycobiological analysis reagents for clinical and medical laboratory usediagnostic preparations and reagents for clinical and medical laboratory use ))
Classe 5
(( Joint function improving agentspharmaceutical preparations for treating arthrosis and other joint diseases; Ophthalmic surgical aidsodium hyaluronate solution used for surgery in and around the eyes; Pharmaceutical preparations for the treatment of disc hernia; Syringes sold filled with pharmaceuticalscrosslinked or non-crosslinked hyaluronic acid based gel for the treatment of arthrosis and osteoarthritis; Syringes sold filled with pharmaceuticalssodium hyaluronate solutions for the treatment of arthrosis and osteoarthritis )) ; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposesdiagnostic reagents for in-vitro clinical diagnostic purposes
Classe 10
Injection syringes ; Injection needles
Publicações
Histórico de despachos e eventos da marca no USPTO.
68 publicações encontradas
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
26/09/2022
INPC
INVALIDATION PROCESSED
26/09/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
22/08/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
22/12/2021
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
22/12/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
16/06/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
28/06/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
28/03/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
13/04/2018
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/03/2018
INPC
INVALIDATION PROCESSED
08/03/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
26/02/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
26/06/2017
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
26/06/2017
71AG
REGISTERED-SEC.71 ACCEPTED
26/06/2017
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
26/06/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
26/06/2017
71AF
REGISTERED-SEC.71 FILED
23/05/2017
15AF
REGISTERED - SEC. 15 AFFIDAVIT FILED
23/05/2017
ES71
TEAS SECTION 71 RECEIVED
23/05/2017
E15R
TEAS SECTION 15 RECEIVED
23/05/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/08/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/03/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/12/2011
FIMP
FINAL DISPOSITION PROCESSED
01/12/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/09/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
28/06/2011
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/04/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/04/2011
PUBO
PUBLISHED FOR OPPOSITION
12/04/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/03/2011
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
24/03/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/03/2011
ALIE
ASSIGNED TO LIE
05/03/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2011
XAEC
EXAMINER'S AMENDMENT ENTERED
08/02/2011
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/02/2011
GNEA
EXAMINERS AMENDMENT E-MAILED
08/02/2011
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/02/2011
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28/01/2011
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/01/2011
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13/01/2011
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/12/2010
GPRA
PRIORITY ACTION E-MAILED
08/12/2010
CPRA
PRIORITY ACTION WRITTEN
08/12/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/09/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/09/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/09/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
26/03/2010
GNRT
NON-FINAL ACTION E-MAILED
26/03/2010
CNRT
NON-FINAL ACTION WRITTEN
26/03/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2010
ALIE
ASSIGNED TO LIE
01/03/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/02/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/02/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/02/2010
RFNT
REFUSAL PROCESSED BY IB
29/09/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/08/2009
RFRR
REFUSAL PROCESSED BY MPU
27/08/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/08/2009
CNRT
NON-FINAL ACTION WRITTEN
24/08/2009
MAFR
APPLICATION FILING RECEIPT MAILED
18/08/2009
DOCK
ASSIGNED TO EXAMINER
14/08/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/08/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/08/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEIKAGAKU ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.